CELLA, CHIARA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.566
AS - Asia 627
EU - Europa 346
SA - Sud America 127
AF - Africa 16
OC - Oceania 3
Totale 2.685
Nazione #
US - Stati Uniti d'America 1.532
SG - Singapore 249
CN - Cina 159
BR - Brasile 106
HK - Hong Kong 91
UA - Ucraina 54
VN - Vietnam 47
DE - Germania 46
FR - Francia 40
GB - Regno Unito 40
RU - Federazione Russa 31
FI - Finlandia 30
IE - Irlanda 27
IT - Italia 26
TR - Turchia 25
IN - India 16
CA - Canada 15
ES - Italia 13
MX - Messico 13
AR - Argentina 10
PL - Polonia 9
SE - Svezia 9
BD - Bangladesh 8
JP - Giappone 8
ZA - Sudafrica 7
AT - Austria 5
LT - Lituania 4
PK - Pakistan 4
BE - Belgio 3
EC - Ecuador 3
IQ - Iraq 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
NL - Olanda 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
DZ - Algeria 2
ID - Indonesia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 2.685
Città #
Fairfield 170
Chandler 131
Ashburn 127
Singapore 116
Hong Kong 91
Woodbridge 83
Seattle 76
Houston 75
Wilmington 69
Princeton 54
The Dalles 53
Los Angeles 50
Cambridge 46
Jacksonville 43
San Jose 34
New York 31
Lauterbourg 30
Helsinki 29
Dublin 27
Beijing 26
Istanbul 21
Ho Chi Minh City 18
Moscow 17
Ann Arbor 16
San Francisco 15
Chicago 14
Shanghai 14
Buffalo 13
Council Bluffs 13
Santa Clara 13
Dallas 12
Redondo Beach 12
Frankfurt am Main 11
London 11
Atlanta 9
Phoenix 9
San Diego 9
Warsaw 9
Chennai 8
Des Moines 8
Rio de Janeiro 8
Stockholm 8
São Paulo 8
Mexico City 7
Tokyo 7
Brooklyn 6
Poplar 6
Hanoi 5
Orem 5
Toronto 5
Boston 4
Denver 4
Düsseldorf 4
Guangzhou 4
Johannesburg 4
Montreal 4
Amman 3
Amsterdam 3
Ankara 3
Belo Horizonte 3
Brussels 3
Charlotte 3
Dhaka 3
Haiphong 3
Hangzhou 3
Milan 3
Munich 3
Nairobi 3
Portsmouth 3
Querétaro 3
Salvador 3
Aparecida de Goiânia 2
Baghdad 2
Brasília 2
Bắc Ninh 2
Calgary 2
Carney 2
Changsha 2
Chongqing 2
City of London 2
Columbus 2
Da Nang 2
Falkenstein 2
Franca 2
Harrisburg 2
Ilhéus 2
Irecê 2
Kilburn 2
Kingston 2
Lahore 2
Manaus 2
Maricá 2
Milwaukee 2
Mumbai 2
Porto Alegre 2
Quận Bình Thạnh 2
Redwood City 2
Ribeirão Preto 2
Ribeirão das Neves 2
Rome 2
Totale 1.805
Nome #
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis 133
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 128
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 128
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis 116
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion of etiopathogenesis and diagnostic tools 113
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside 107
Digital Ischemia in Patients with Solid Tumors: a Case Report and Review of the Literature 102
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors 100
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients 100
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 100
Bevacizumab maintenance in metastatic colorectal cancer: How long? 96
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors 95
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 94
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms 94
Treatments for colorectal liver metastases: A new focus on a familiar concept 93
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? 92
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 92
The Italian Rare Pancreatic Exocrine Cancer Initiative 91
Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma? 90
Basaloid squamous cell carcinoma: a rare tumor at the esophagogastric junction and an unexpected durable complete response to FOLFOX-4 89
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives 88
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 79
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 77
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 76
High-risk human papillomavirus in anal squamous cell carcinoma: A 'conservative' leading role 73
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report 72
The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era 67
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials 67
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor 64
Totale 2.716
Categoria #
all - tutte 16.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022178 0 42 3 11 1 9 15 21 13 6 7 50
2022/2023290 27 0 3 50 14 83 1 32 54 0 9 17
2023/2024156 20 3 11 29 1 10 3 10 34 1 4 30
2024/2025452 0 1 1 67 43 51 48 28 37 46 78 52
2025/2026980 99 116 83 188 147 61 103 21 29 94 37 2
Totale 2.716